Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study

INTRODUCTION: To describe the efficacy of subcutaneous immunoglobulin (SCIg) in patients with myasthenia gravis (MG). METHODS: This was a retrospective study conducted in the neuromuscular referral center of Bordeaux (between January 1, 2014 and March 31, 2021) with MG patients treated with SCIg. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnay, Marlène, Duval, Fanny, Solé, Guilhem, Carla, Louis, Mathis, Stéphane, Le Masson, Gwendal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395862/
https://www.ncbi.nlm.nih.gov/pubmed/35995991
http://dx.doi.org/10.1007/s00415-022-11345-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395862/
https://www.ncbi.nlm.nih.gov/pubmed/35995991
http://dx.doi.org/10.1007/s00415-022-11345-y

Ejemplares similares